Crossmark

Impact of Wilms’ tumor 1 gene (WT1) mutation on outcome of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia: a retrospective multicenter cohort study from the ALWP/EBMT registry

Crossref DOI link: https://doi.org/10.1038/s41409-025-02727-7

Published Online: 2025-10-16

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagler, Arnon https://orcid.org/0000-0002-0763-1265
Esteve, Jordi https://orcid.org/0000-0002-8056-648X
Galimard, Jacques-Emmanuel https://orcid.org/0000-0001-9102-4427
Sanz, Jaime https://orcid.org/0000-0001-6934-4619
Poire, Xavier https://orcid.org/0000-0003-1897-0227
Collin, Matthew

Maertens, Johan https://orcid.org/0000-0003-4257-5980
Huang, He

Itäla-Remes, Maija

Halahleh, Khalid https://orcid.org/0000-0002-1161-9138
Pascual Cascon, Maria Jesús

Chiusolo, Patrizia https://orcid.org/0000-0002-1355-1587
Griskevicius, Laimonas

Kaare, Ain https://orcid.org/0000-0002-3170-1016
De Becker, Ann https://orcid.org/0000-0003-0947-8708
Jindra, Pavel https://orcid.org/0000-0002-8415-7069
Pérez-Simón, Jose Antonio https://orcid.org/0000-0003-3616-6101
Bazarbachi, Ali https://orcid.org/0000-0002-7171-4997
Brissot, Eolia https://orcid.org/0000-0003-4471-418X
Ciceri, Fabio https://orcid.org/0000-0003-0873-0123
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
License Information

Text and Data Mining valid from 2025-10-16

Version of Record valid from 2025-10-16
More Information

Article History

Received: 7 July 2025

Revised: 31 August 2025

Accepted: 22 September 2025

First Online: 16 October 2025

Competing interests

: The authors declare no competing interests.

: The scientific boards of the ALWP of the EBMT approved this study.